L-theanine for sleep: dose, timing, and who it helps

More than one in three American adults sleeps less than seven hours a night, according to long-running CDC surveillance, and insomnia symptoms touch roughly a third of adults in any given year. L-theanine — an amino acid found almost exclusively in tea leaves — has become one of the most-searched sleep supplements in the US, UK, Canada and Australia. The honest framing, before any bottle is opened: theanine is not a sedative, and it will not put anyone to sleep. What small but consistent trials suggest is narrower and more useful — it may quiet the stress-driven arousal that keeps a tired brain awake. That distinction decides who benefits and who wastes money.

What the research shows, with the numbers

L-theanine was isolated from green tea in 1949 and gives tea its savoury, umami edge. A brewed cup contains well under 50 mg; the doses tested in trials — 200 to 400 mg — are only reachable with a supplement.

The best-known trial, published in Nutrients in 2019 by Japanese researchers (Hidese and colleagues), randomised 200 adults with stress-related symptoms to 200 mg of L-theanine or placebo daily for four weeks. The theanine group scored better on the Pittsburgh Sleep Quality Index and on self-rated stress measures than the placebo group. Earlier, a 2011 Canadian randomised trial (Lyon and colleagues) gave 98 boys with ADHD 200 mg twice daily and found objectively better sleep on actigraphy — measured by wrist monitor, not questionnaire. A 2019 Australian trial (Sarris and colleagues) in adults with generalised anxiety disorder used 450–900 mg daily for eight weeks and reported improved sleep-quality scores as a secondary outcome.

The mechanism is plausible: EEG studies show theanine increases alpha-band brain waves of 8 to 13 hertz, the signature of relaxed wakefulness, typically within 30 to 60 minutes of ingestion. Researchers believe it modulates glutamate signalling, the brain's main excitatory system, which may explain why it blunts tension without sedation.

Why it matters

If the problem is falling asleep — lying wound up, replaying the day — the trial evidence points to a specific, low-risk intervention: 200 mg taken 30 to 60 minutes before bed. Unlike older antihistamine sleep aids, theanine produced no next-day grogginess in trials and no evidence of dependence or rebound. It is inexpensive, typically 10 to 30 cents a night, and was well tolerated at every dose studied, including up to 900 mg a day.

It matters equally what it does not do. Theanine will not fix sleep apnea, restless legs, chronic pain, a snoring partner or a 6 a.m. alarm after a midnight shift. Anyone who snores loudly and wakes unrefreshed needs an evaluation for apnea, not an amino acid.

The honest counterpoint

The strongest scientific objection is that the evidence base is thin. Most trials enrol 50 to 200 people, run four to eight weeks, and several were funded by ingredient manufacturers. Outcomes skew toward subjective questionnaires; there is no consistent evidence that theanine lengthens objectively measured total sleep time or increases deep sleep in healthy adults. Systematic reviewers have repeatedly rated the overall quality of evidence as low to moderate.

That objection is fair, and it does not quite land the knockout. Theanine is not competing with prescription hypnotics; it targets pre-sleep arousal, and its improvements cluster exactly where the mechanism predicts — subjective sleep quality in stressed or anxious people. On safety, the US FDA has recognised L-theanine as generally recognised as safe (GRAS) since 2007, and Health Canada licenses it as a natural health product for relaxation. Our editorial position, stated plainly: for stress-related trouble falling asleep, a four-week trial of 200 mg at night is a reasonable, low-risk experiment. For diagnosed chronic insomnia, cognitive behavioural therapy for insomnia (CBT-I) remains the first-line treatment recommended by the American College of Physicians. Theanine, at best, is an adjunct — not a replacement.

Dose and timing

• Dose: 200 mg is the workhorse dose across trials; 200–400 mg daily has been studied, and up to 900 mg/day was tested in the anxiety trial without significant adverse effects.
• Timing: 30–60 minutes before bed, aligned with when EEG changes first appear.
• Patience: give it two to four weeks before judging — the 2019 RCT ran four weeks.
• Skip the tea trick: a cup of green tea delivers well under 50 mg of theanine alongside roughly 30–50 mg of caffeine, which works against sleep.
• Combinations: no solid head-to-head data support stacking it with melatonin or magnesium, despite the crowded shelves of combination products.

Who it helps — and who it does not

Best candidates are adults whose main complaint is a racing mind at lights-out, heavy caffeine users cutting back, and people whose stress or anxiety disrupts sleep — the populations actually studied. Objective improvements were even recorded in children with ADHD, though paediatric dosing belongs with a paediatrician.

Poor candidates include anyone with untreated apnea, shift workers fighting circadian misalignment, and people with depression-related insomnia. Pregnant or breastfeeding women should not take it: trials excluded them and safety data do not exist. Anyone on blood-pressure medication should flag the supplement with a pharmacist, as mild BP-lowering effects have been reported in some studies.

Bottom line

L-theanine is a modest, mechanism-plausible, safety-friendly option for the "wired and tired" sleeper: 200 mg, 30 to 60 minutes before bed, judged over a month. It is not a cure, not a sedative, and no substitute for treating the real cause of chronic poor sleep.